glp-1 medullary thyroid cancer risk of with glp 1 receptor agonist use for more than year may increase GLP-1 Receptor Agonists and Thyroid – More Thyroid Cancers Found After

Researchers at Penn Engineering are now looking into an experimental weight loss drug developed by Eli Lilly, known as retatrutide, commonly known as triple G

To better understand the human side of the GLP-1 divide, The Health Management Academy surveyed 1,827 Americans in November 2025 to capture the real-world impact of the GLP-1 divide, highlighting the emotional, social, and financial toll it takes across different incomes and between men and women

When I asked to speak with a person, it requested my full name, birthday, and current address

Tracking your progress on GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) is essential for optimizing treatment outcomes and safety